Israel Englander Pharvaris N.V. Put Options Transaction History
Millennium Management LLC
- $192 Billion
- Q4 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding PHVS
# of Institutions
52Shares Held
39.1MCall Options Held
0Put Options Held
0-
General Atlantic LLC New York, NY7.53MShares$131 Million5.17% of portfolio
-
Foresite Capital Management Iv, LLC Larkspur, CA4.4MShares$76.4 Million77.49% of portfolio
-
Ven Bio Partners LLC San Francisco, CA4.29MShares$74.5 Million67.66% of portfolio
-
Viking Global Investors LP3.65MShares$63.5 Million0.24% of portfolio
-
Bain Capital Life Sciences Investors, LLC Boston, MA3.3MShares$57.4 Million17.1% of portfolio
About Pharvaris N.V.
- Ticker PHVS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 33,766,000
- Market Cap $587M
- Description
- Pharvaris N.V., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases. The company develops PHA121, a small molecule bradykinin B2-receptor antagonist that is in Phase II clinical trial for the treatment of hereditary angioedema (HAE). It also develops PHVS416, an on-demand, r...